ACAD
NEGATIVE BIASACADIA Pharmaceuticals Inc. · Healthcare
$21.58-4.39%LAST CLOSE
24H-4.39%
1W-2.79%
1M-1.78%
1Y+53.05%
Live Chart · ACAD
1DNY TIME
BOGA Master Score
46.2
High conviction score
BOGA AI Model Projection
Strategic Observation Zone$21.47 - $21.69
Projected Growth Objective$23.65 - $25.34
Model Invalidation Level$18.89 - $19.88
Risk/Reward1.5:1
AD-S2 · 300×250 Sidebar
Technical Indicators
RSI (14)
45.5
Neutral
MACD
0.184
NEUTRAL
RVOL
0.64x
Normal
Trends
UP
UP
EMA Stack
Bearish
STABLE
BB Squeeze
MEDIUM
MONITOR
Fundamentals & Margins
Market Cap
P/E Ratio
vs Sector: 25.0730915
FCF Yield
Gross Margin
Operating Margin
Net Margin
Sector Context
Benchmarked against
XLV
5D Performance
+1.3%
ACAD is currently ranked in the top 20% of its sector based on BOGA Master Scores. It has outperformed XLV by 4.2% over the last 30 trading days.
Insider Activity (90D)
| Transaction | Shares | Net Direction |
|---|---|---|
| Buys | 0 | SELL |
| Sells | 8 |
Last Transaction: SELL 1030 shares

Share This Insight
Help others discover this score. Professional analysts share high-conviction data.
Share This Insight
Help others discover this score. Professional analysts share high-conviction data.